Girl’s death in China reveals human cost of unregulated science
The story in brief
A six-year-old girl died after an experimental gene-editing treatment in China, developed by Zilong Qiu at Shanghai Jiao Tong University for Snijders Blok-Campeau syndrome. The therapy used base-editing to correct a genetic mutation in her brain cells. The hospital faced fines for trial oversight issues. Her death, not disclosed initially, sparked debate over risks and oversight in 'first in human' gene-editing trials.